Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

The antibody-drug conjugate showed a higher objective response rate but failed to meet the primary OS endpoint in patients ...

Learn about pediatric low-grade glioma symptoms, causes, diagnosis, and treatment. Understand risk factors and prevention to ...

Before the law, there was no cap on what Medicare enrollees might have to spend on medications covered by their Part D drug plans.

Kate Middleton’s cancer diagnosis was big health news in 2024, with other famous names like Lance Bass and Wendy Williams ...

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and ...

The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and renal ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Researchers describe a new potential role for oleanic acid as a modulator of the DNA damage response following camptothecin ...

“She just had to put out $14,000 to completely restore and get a whole new septic system in her house because the chemo ...